{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T09:02:06Z","timestamp":1780909326518,"version":"3.54.1"},"reference-count":50,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:00:00Z","timestamp":1780790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Background\/Objectives: The gene solute carrier family 52 member 3 (SLC52A3) encodes riboflavin transporter-3, a transmembrane protein essential for riboflavin absorption. Emerging evidence suggests that metabolic transporters may play a role in tumor biology. This study aimed to investigate the expression patterns, prognostic significance, genetic alterations, and functional associations of SLC52A3 in gynecological cancers. Methods: A comprehensive bioinformatic analysis was conducted using multi-omics datasets from The Cancer Genome Atlas (TCGA). Gene expression and survival analyses were performed via GEPIA3. Genetic alterations, including mutations and copy number variations, were assessed using cBioPortal. Immune infiltration correlations were analyzed through TIMER3. Protein\u2013protein interactions and gene enrichment analyses were performed using STRING and GEPIA2, followed by Gene Ontology (GO) and KEGG pathway analyses. Results: SLC52A3 expression was significantly upregulated in ovarian, cervical, and endometrial cancers. Reduced expression of SLC52A3 was associated with poorer overall survival and shorter progression-free interval specifically in endometrial cancer. Genetic alterations in SLC52A3 were not significantly associated with survival outcomes (OS, DFS, and PFS). Functional enrichment analysis indicated that SLC52A3 is involved in biological processes such as cell junction organization and protein localization to the plasma membrane. Additionally, SLC52A3 expression showed positive correlations with genes implicated in tumor progression and metastasis, including NECTIN4, PROM2, TACSTD2, PKP3, SEMA4B, and CD46. Conclusions: These findings suggest that SLC52A3 may serve as a potential prognostic biomarker in endometrial cancer and could play a role in tumor progression pathways. Its functional associations highlight its potential relevance as a therapeutic target, warranting further experimental validation.<\/jats:p>","DOI":"10.3390\/genes17060669","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T07:43:02Z","timestamp":1780904582000},"page":"669","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Comprehensive Bioinformatic Analysis of SLC52A3 as a Prognostic Biomarker and Potential Therapeutic Target in Gynecological Cancers"],"prefix":"10.3390","volume":"17","author":[{"given":"Monia","family":"Cecati","sequence":"first","affiliation":[{"name":"Department for the Promotion of Human Science and Quality of Life, San Raffaele Roma University, 00166 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9943-3908","authenticated-orcid":false,"given":"Valentina","family":"Schiavoni","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Polytechnic University of Marche, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2607-2734","authenticated-orcid":false,"given":"Roberto","family":"Campagna","sequence":"additional","affiliation":[{"name":"Department for the Promotion of Human Science and Quality of Life, San Raffaele Roma University, 00166 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7003-1230","authenticated-orcid":false,"given":"Giovanni","family":"Tossetta","sequence":"additional","affiliation":[{"name":"Department for the Promotion of Human Science and Quality of Life, San Raffaele Roma University, 00166 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,7]]},"reference":[{"key":"ref_1","unstructured":"(2020). Pan-Cancer Analysis of Whole Genomes. The ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium. Nature, 578, 82\u201393."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1080\/14737140.2024.2438951","article-title":"NRF2\/KEAP1 signaling inhibitors in gynecologic cancers","volume":"24","author":"Fantone","year":"2024","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Cecati, M., Pozzi, V., Pompei, V., Schiavoni, V., Fumarola, S., Romagnoli, A., Tossetta, G., Montana, A., Polizzi, A., and Sartini, D. (2026). Cisplatin as a Xenobiotic Agent: Molecular Mechanisms of Actions and Clinical Applications in Oncology. J. Xenobiot., 16.","DOI":"10.3390\/jox16010009"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"175503","DOI":"10.1016\/j.ejphar.2023.175503","article-title":"Targeting the NRF2\/KEAP1 pathway in cervical and endometrial cancers","volume":"941","author":"Tossetta","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Fantone, S., Piani, F., Olivieri, F., Rippo, M.R., Sirico, A., Di Simone, N., Marzioni, D., and Tossetta, G. (2024). Role of SLC7A11\/xCT in Ovarian Cancer. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25010587"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.3945\/jn.110.128330","article-title":"Functional characteristics of the human ortholog of riboflavin transporter 2 and riboflavin-responsive expression of its rat ortholog in the small intestine indicate its involvement in riboflavin absorption","volume":"140","author":"Fujimura","year":"2010","journal-title":"J. Nutr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.3945\/jn.110.122911","article-title":"Identification and comparative functional characterization of a new human riboflavin transporter hRFT3 expressed in the brain","volume":"140","author":"Yao","year":"2010","journal-title":"J. Nutr."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Subramanian, V.S., Ghosal, A., Kapadia, R., Nabokina, S.M., and Said, H.M. (2015). Molecular Mechanisms Mediating the Adaptive Regulation of Intestinal Riboflavin Uptake Process. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0131698"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Aili, A., Hasim, A., Kelimu, A., Guo, X., Mamtimin, B., Abudula, A., and Upur, H. (2013). Association of the plasma and tissue riboflavin levels with C20orf54 expression in cervical lesions and its relationship to HPV16 infection. PLoS ONE, 8, Correction in PLoS ONE 2014, 9, e103377. https:\/\/doi.org\/10.1371\/journal.pone.0103377.","DOI":"10.1371\/journal.pone.0103377"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e24287","DOI":"10.1016\/j.heliyon.2024.e24287","article-title":"KLK10\/LIPH\/PARD6B\/SLC52A3 are promising molecular biomarkers for the prognosis of pancreatic cancer through a ceRNA network","volume":"10","author":"Zhang","year":"2024","journal-title":"Heliyon"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1007\/s00018-018-2757-4","article-title":"SLC52A3 expression is activated by NF-kappaB p65\/Rel-B and serves as a prognostic biomarker in esophageal cancer","volume":"75","author":"Long","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/WNR.0000000000000674","article-title":"Overexpression of riboflavin transporter 2 contributes toward progression and invasion of glioma","volume":"27","author":"Fu","year":"2016","journal-title":"Neuroreport"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.canlet.2014.07.013","article-title":"RFT2 is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenesis by sustaining cell proliferation and protecting against cell death","volume":"353","author":"Jiang","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"W283","DOI":"10.1093\/nar\/gkaf423","article-title":"GEPIA3: Enhanced drug sensitivity and interaction network analysis for cancer research","volume":"53","author":"Kang","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"W534","DOI":"10.1093\/nar\/gkaf388","article-title":"TIMER3: An enhanced resource for tumor immune analysis","volume":"53","author":"Cui","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Tang, D., Chen, M., Huang, X., Zhang, G., Zeng, L., Zhang, G., Wu, S., and Wang, Y. (2023). SRplot: A free online platform for data visualization and graphing. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0294236"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1042\/BCJ20190767","article-title":"Blackout in the powerhouse: Clinical phenotypes associated with defects in the assembly of OXPHOS complexes and the mitoribosome","volume":"477","author":"Hock","year":"2020","journal-title":"Biochem. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cancergen.2025.08.010","article-title":"Comprehensive analysis of oncogenic determinants across tumor types via multi-omics integration","volume":"298\u2013299","author":"Ubaid","year":"2025","journal-title":"Cancer Genet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"189149","DOI":"10.1016\/j.bbcan.2024.189149","article-title":"Exploring the impact of flavin homeostasis on cancer cell metabolism","volume":"1879","author":"Nisco","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.2174\/092986710793205462","article-title":"Emerging roles for riboflavin in functional rescue of mitochondrial beta-oxidation flavoenzymes","volume":"17","author":"Henriques","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: Integrating immunity\u2019s roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Zhang, M., Chen, Z., Wang, Y., Zhao, H., and Du, Y. (2022). The Role of Cancer-Associated Fibroblasts in Ovarian Cancer. Cancers, 14.","DOI":"10.3390\/cancers14112637"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Dasari, S., Fang, Y., and Mitra, A.K. (2018). Cancer Associated Fibroblasts: Naughty Neighbors That Drive Ovarian Cancer Progression. Cancers, 10.","DOI":"10.3390\/cancers10110406"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1042\/BST20160387","article-title":"Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis","volume":"45","author":"Erdogan","year":"2017","journal-title":"Biochem. Soc. Trans."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/ajco.14201","article-title":"Dynamics of Serum Inflammatory Markers Predict Survival After Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer","volume":"22","author":"Lee","year":"2026","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cancergen.2025.03.004","article-title":"Identification of new immune target and signaling for cancer immunotherapy","volume":"294\u2013295","author":"Narote","year":"2025","journal-title":"Cancer Genet."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Yu, Y., and Elble, R.C. (2016). Homeostatic Signaling by Cell-Cell Junctions and Its Dysregulation during Cancer Progression. J. Clin. Med., 5.","DOI":"10.3390\/jcm5020026"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41568-023-00574-6","article-title":"Endocytosis in cancer and cancer therapy","volume":"23","author":"Banushi","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"a016949","DOI":"10.1101\/cshperspect.a016949","article-title":"Endocytosis and cancer","volume":"5","author":"Mellman","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Katoh, M., Loriot, Y., Nakayama, I., Hamada, A., Shitara, K., and Katoh, M. (2025). Antibody-drug conjugates targeting the cadherin, claudin and nectin families of adhesion molecules. Front. Mol. Med., 5.","DOI":"10.3389\/fmmed.2025.1661016"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41417-019-0109-7","article-title":"PROM1 and PROM2 expression differentially modulates clinical prognosis of cancer: A multiomics analysis","volume":"27","author":"Saha","year":"2020","journal-title":"Cancer Gene Ther."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Li, X.X., and Chen, J.L. (2025). TROP2: As a promising target in lung cancer. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1569897"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/cas.16019","article-title":"Role and function of plakophilin 3 in cancer progression and skin disease","volume":"115","author":"Zhang","year":"2024","journal-title":"Cancer Sci."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Jiang, J., Lu, Y., Zhang, F., Pan, T., Zhang, Z., Wan, Y., Ren, X., and Zhang, R. (2022). Semaphorin 4B promotes tumor progression and associates with immune infiltrates in lung adenocarcinoma. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-09696-w"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.21873\/anticanres.18135","article-title":"Inhibition of AP-1 Reduces CD46-mediated Invasion of Bladder and Colon Cancer Cells","volume":"46","author":"Thi","year":"2026","journal-title":"Anticancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"9717","DOI":"10.18632\/oncotarget.14206","article-title":"The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate","volume":"8","author":"Boylan","year":"2017","journal-title":"Oncotarget"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.ejca.2009.12.019","article-title":"Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients","volume":"46","author":"Bignotti","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Bignotti, E., Zanotti, L., Calza, S., Falchetti, M., Lonardi, S., Ravaggi, A., Romani, C., Todeschini, P., Bandiera, E., and Tassi, R.A. (2012). Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma. BMC Clin. Pathol., 12.","DOI":"10.1186\/1472-6890-12-22"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.bbrc.2018.11.163","article-title":"PKP3 interactions with MAPK-JNK-ERK1\/2-mTOR pathway regulates autophagy and invasion in ovarian cancer","volume":"508","author":"Lim","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.2174\/1871520623666230905104555","article-title":"Knockdown of PROM2 Enhances Paclitaxel Sensitivity in Endometrial Cancer Cells by Regulating the AKT\/FOXO1 Pathway","volume":"23","author":"Jiang","year":"2023","journal-title":"Anticancer Agents Med. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Yu, J.H., Yuan, H.B., Yan, Z.Y., Zhang, X., and Xu, H.H. (2024). The complement regulatory protein CD46 serves as a novel biomarker for cervical cancer diagnosis and prognosis evaluation. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1421778"},{"key":"ref_44","first-page":"4943","article-title":"CD46 expression is indicative of shorter revival-free survival for ovarian cancer patients","volume":"26","author":"Surowiak","year":"2006","journal-title":"Anticancer Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"104627","DOI":"10.1016\/j.ebiom.2023.104627","article-title":"A pentasaccharide for monitoring pharmacodynamic response to gene therapy in GM1 gangliosidosis","volume":"92","author":"Kell","year":"2023","journal-title":"eBioMedicine"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1158\/1078-0432.CCR-07-4535","article-title":"Validation of analytic methods for biomarkers used in drug development","volume":"14","author":"Chau","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/1535370217750088","article-title":"Biomarker definitions and their applications","volume":"243","author":"Califf","year":"2018","journal-title":"Exp. Biol. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jtho.2021.01.1616","article-title":"Biomarker Discovery and Validation: Statistical Considerations","volume":"16","author":"Ou","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/jnci\/dji237","article-title":"The Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics. Reporting recommendations for tumor marker prognostic studies (REMARK)","volume":"97","author":"McShane","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/1354750X.2025.2515363","article-title":"Biosensor driven biomarker analysis: Pioneering advancements in cancer diagnosis and therapeutic strategies","volume":"30","author":"Nimhan","year":"2025","journal-title":"Biomarkers"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/17\/6\/669\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T08:16:29Z","timestamp":1780906589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/17\/6\/669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,7]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["genes17060669"],"URL":"https:\/\/doi.org\/10.3390\/genes17060669","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,7]]}}}